In stroke patients with atrial fibrillation (AF) and cardiovascular disease (CVD), adding an antiplatelet to an oral anticoagulant (OAC) does not reduce ischemic events and more than doubles bleeding ...
In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...
The safety and efficacy of strategies for dual antiplatelet therapy (DAPT) de-escalation following PCI may vary depending on patient sex, especially when switching to a single antiplatelet agent, ...
Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone – and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...
MADRID — New data from two randomized trials suggest that dual antiplatelet therapy (DAPT) should be significantly shortened or not used at all after coronary artery bypass surgery (CABG). Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback